Quest Diagnostics has completed its acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from an approximately 200,000-square-feet facility in Lewisville, Texas, the two businesses form the basis for Quest’s first national center for precision oncology diagnostics. In connection with the transaction, Quest is now a preferred provider for several organizations that are formerly owners of one or both of these businesses. These organizations include Baylor Scott & White Health (BSWH), the U.S. Oncology Network (The Network), Texas Oncology, and Pathologists Bio-Medical Laboratories. Quest will provide services on a preferred basis to 12 BSWH hospitals in North Texas and 1,400 independent, community-based physicians nationally that are affiliated with The Network, including Texas Oncology. In addition, Quest Diagnostics will collaborate with McKesson Specialty Health, The Network, and Texas Oncology to enhance and expand nationally a model created by Med Fusion that standardizes next-generation sequencing panels to help providers select therapy and monitor for cancer.